Trump Answers Scott Adams’ Plea for Life-Saving Cancer Drug
The phrase “help is on the way” has never sounded more urgent than it does for Scott Adams, the famed creator of the Dilbert comic strip and a staunch supporter of President Donald Trump (R). Facing the grim diagnosis of advanced, metastatic prostate cancer, Adams has taken his battle public, pleading with Trump and the nation to help cut through bureaucratic delays to get the newly-approved cancer therapy, Pluvicto. His appeal to the president isn’t just the latest in a string of personal requests for help—it has shone a harsh light on America’s tangled healthcare system and the vital role that leadership can play when a citizen’s life is hanging in the balance. On Sunday, Adams posted online that he was “declining fast” and needed Trump to save his life by securing a Pluvicto treatment his insurance was slow to provide, a desperate message that quickly reverberated across conservative media.
Scott Adams’ struggle is not an isolated one. Many Americans facing deadly diagnoses find themselves caught up in red tape, while insurance providers drag their feet on approving or scheduling critical treatments. Adams’ prominence as an outspoken voice—and his longstanding, positive relationship with President Trump—helped his urgent plea cut through the noise of daily headlines. In a powerful affirmation of leadership in action, Trump responded to Adams’ direct appeal with just two words that lit up the conservative internet: “On it!” This is precisely the kind of leadership that Americans elected in 2024—results-driven, compassionate, and unafraid to take action where bureaucracies fail.
The clock is ticking for Adams, who has candidly shared the swift decline in his health, saying he is using a walker and fighting daily pain. With Pluvicto approved by the Food and Drug Administration in 2022 for advanced, resistant cases, Adams has tried to secure the treatment through Kaiser Permanente. But delays in scheduling his infusion led to his extraordinary appeal to the White House and, by extension, to the entire Trump administration. This intersection of personal struggle, political leadership, and healthcare bureaucracy is now playing out on the national stage in real time, watched closely by both Trump supporters and those skeptical of his style.
“On Monday, I will ask President Trump, via X, to help save my life. He offered to help me if I needed it. I am declining fast.” — Scott Adams, via social media, November 2, 2025
As this drama unfolds, all eyes are on Trump to see whether his trademark decisiveness and knack for results can once again deliver where the system itself stumbles.
White House and Conservative Leaders Rally for Pluvicto Access
Within hours of Adams’ social media post, a chorus of support began to emerge from the highest levels of the federal government. White House Deputy Chief of Staff Dan Scavino posted that President Trump (R), Health and Human Services Secretary Robert F. Kennedy Jr. (D), and Dr. Mehmet Oz were “all tracking now, Scott,” putting a national spotlight on both the urgency of Adams’ situation and the Trump administration’s commitment to getting results. The administration didn’t wait for a Monday morning memo or a committee meeting—it moved immediately to address Adams’ needs. This is the America First promise at work: no American is forgotten, and every fight is worth fighting if it means one more life can be saved.
The cancer drug at the center of the drama, Pluvicto, isn’t just experimental hope. It is a targeted, cutting-edge therapy that was greenlit by the FDA in 2022 and has helped extend lives for patients whose prostate cancer is resistant to hormone and chemotherapy. While not a cure, it’s a lifeline to men like Adams. His insurance provider, Kaiser Permanente, confirmed that their oncology team had already treated more than 150 patients with Pluvicto since 2022, underscoring the experience and capability of American providers to handle this advanced therapy (Kaiser Permanente’s oncology teams have treated over 150 patients with Pluvicto since its 2022 approval).
Yet, even with apparent capability, Adams was still caught in a web of insurance-driven delays. The personal nature of his request to Trump highlights both the frustration many patients feel with the medical establishment and the unique confidence many Americans now place in direct executive action over entrenched bureaucracy. Many in the mainstream press, such as the San Francisco Chronicle, have critiqued this as a symptom of “transactional” relationships and alleged distrust of medical expertise—failing to recognize that for everyday Americans, outcomes matter more than process (SF Chronicle highlighted the personal and transactional nature of Scott Adams’ appeal to President Trump).
White House Deputy Chief of Staff Dan Scavino: “No need till [sic] wait until Monday – @realDonaldTrump, @RobertKennedyJr, and @DrOz are all tracking now, Scott.”
Conservative Americans aren’t interested in endless red tape—they want a government that gets the job done, a leader who fights for every citizen, and a health system that delivers when the chips are down. Scott Adams’ story is the latest and most personal flashpoint in this fight for healthcare accountability and real-world solutions.
Health Care Red Tape, Pluvicto Delays, and Trump’s America First Response
Scott Adams’ very public struggle is a reflection of a much larger problem: the layers of bureaucracy, insurance stalling, and medical establishment inertia that too often determine life-and-death outcomes for ordinary Americans. Too many are aware of the pain of waiting for a phone call or appointment that may decide their future. What sets Adams’ case apart is not only his fame, but his willingness to leverage his own public platform—and his relationship with President Trump—to move the needle.
The heart of the controversy is Pluvicto. This breakthrough treatment has given hope to late-stage prostate cancer patients since its FDA approval in 2022. According to cancer experts, the drug can shrink tumors and extend the lives of men for whom other therapies have failed (Pluvicto… can extend life for some men with metastatic prostate cancer). But for Adams, whose cancer has already spread to his bones and for whom each day is a fight against pain and decline, delayed access to this treatment could literally be the difference between life and death. The national attention has thrown a spotlight not only on Adams’ pain but on the crucial need for streamlining how life-saving medicine gets to those who need it most.
President Trump’s (R) characteristically direct approach to Adams’ appeal has once again demonstrated why millions of Americans chose his America First leadership in the 2024 election and why conservatives continue to rally around him in moments of crisis. Where technocratic foot-dragging leaves families in limbo, the Trump White House has repeatedly shown that it’s willing to act—swiftly and personally—to ensure that no American is left fighting alone.
Scott Adams: “I am declining fast.”
His words ring out as a call not just for personal aid, but for lasting change in the American medical system—a system that should put patients and families first, not insurance adjusters and scheduling grids.
For conservative Americans, the lesson couldn’t be clearer: Strong, compassionate leadership matters. Scott Adams’ ordeal serves as both an urgent challenge and an opportunity for the administration to prove—once again—that in Trump’s America, every citizen matters, every voice counts, and every fight is worth waging when it comes to life, liberty, and hope.